HS014, a selective melanocortin-4 (MC4) receptor antagonist, modulates the behavioral effects of morphine in mice

Psychopharmacology

Volumn 180, Issue 2, 2005, Pages 279-285

  Ercil, N Eser ^a,b   Galici, Ruggero ^a   Kesterson, Robert A ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 301 Wilson Hall ^*  (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

A y mice; Agouti; Antinociception; HS014; Locomotor activity; MC4 receptor; Melanocortin; Morphine; Proopiomelanocortin; Sensitivity

Indexed keywords

BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN RECEPTOR 4 ANTAGONIST; MORPHINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GENETIC MODEL; HOT PLATE TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MOTOR ACTIVITY; PEPTIDES, CYCLIC; RECEPTOR, MELANOCORTIN, TYPE 4;

EID: 21344434553     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2166-x     Document Type: Article

References (54)

1. Adan RA, Gispen WH (2000) Melanocortins and the brain: from effects via receptors to drug targets. Eur J Pharmacol 405:13-24
2. Alvaro JD, Tatro JB, Duman RS (1997) Melanocortins and opiate addiction. Life Sci 61:1-9
3. Bagnol D, Lu X-Y, Kaelin CB, Day HEW, Ollmann M, Gantz I, Akil H, Barsh GS, Watson SJ (1999) Anatomy of an endogenous antagonist: relationship between agouti-related protein and proopiomelanocortin in brain. J Neurosci 19:1-7
4. Belknap JK, Riggan J, Cross S, Young ER, Gallaher EJ, Crabbe JC (1998) Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol Biochem Behav 59:353-360
5. Bellasio S, Nicolussi E, Bertorellli R, Reggiani A (2003) Melanocortin receptor agonists and antagonists modulate nociceptive sensitivity in the mouse formalin test. Eur J Pharmacol 482:127-132
6. Besse D, Lombard MC, Zajac JM, Roques BP, Besson JM (1990) Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 521:15-22
7. Brase DA, Loh HH, Way EL (1977) Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains. J Pharmacol Exp Ther 201:368-374
8. Castellano C, Oliverio A (1975) A genetic analysis of morphine-induced running and analgesia in the mouse. Psychopharmacologia 41:197-200
9. Collett BJ (1998) Opioid tolerance: the clinical perspective. Br J Anaesth 81:58-68
10. Collett BJ (2001) Chronic opioid therapy for non-cancer pain. Br J Anaesth 87:133-143
11. Cone RD (2000) The melanocortin-4 receptor. In: Cone RD (ed) The melanocortin receptors. Humana Press, New Jersey, pp 173-207
12. Contarino A, Picetti R, Matthes HW, Koob GF, Kieffer BL, Gold LH (2002) Lack of reward and locomotor stimulation induced by heroin in μ-opioid receptor-deficient mice. Eur J Pharmacol 446:103-109
13. Contreras PC, Takemori AE (1984) Antagonism of morphine-induced analgesia, tolerance and dependence by α-melanocyte stimulating hormone. J Pharmacol Exp Ther 299:21-26
14. Eidelberg E, Erspamer R, Kreinick CJ, Harris J (1975) Genetically determined differences in the effects of morphine on mice. Eur J Pharmacol 32:329-336
15. Elmer GI, Pieper JO, Negus SS, Woods JH (1998) Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain 75(1):129-140
16. Fan W, Boston BA, Kesterson RA, Hruby WJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
17. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic Press, San Diego, CA
18. Grossman HC, Hadjimarkou MM, Silva RM, Giraudo SQ, Bodnar RJ (2003) Interrelationships between mu opioid and melanocortin receptors in mediating food intake in rats. Brain Res 991(1-2):240-244
19. Hill HF, Chapman CR, Kornell JA, Sullivan KM, Saeger LC, Benedetti C (1990) Self-administration of morphine in bone marrow transplant patients reduces drug requirement. Pain 40:121-129
20. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
21. Kask A, Schiöth HB (2000) Tonic inhibition of food intake during inactive phase is reversed by the injection of the melanocortin receptor antagonist into the paraventricular nucleus of the hypothalamus and central amygdala of the rat. Brain Res 887:460-464
22. Kask A, Pähkla R, Irs A, Rägo L, Wikberg JES, Schiöth HB (1999) Long-term administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. NeuroReport 10:707-711
23. Kieffer BL (2000) Opioid receptors: from genes to mice. J Pain 1(3 Suppl):45-50
24. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, Elmquist JE (2003) Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. J Comp Neurol 457:213-235
25. Locke KW, Holtzman SG (1986) Behavioral effects of opioid peptides selective for mu and delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats. J Pharmacol Exp Ther 238:997-1003
26. Low MJ, Simerly RB, Cone RD (1994) Receptors for the melanocortin peptides in the central nervous system. Curr Opin Endocrinol Diabetes 1:79-88
27. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychok RP, Wilkinson WO, Cone RD (1994) Agouti protein is an antagonist of the melanocyte stimulating hormone receptor. Nature 371(6500):799-802
28. MacPherson RD (2000) The pharmacological basis of contemporary pain management. Pharmacol Ther 88:163-185
29. Magni G (1991) The use of antidepressants in the treatment of chronic pain. Drugs 42:730-748
30. Martin TJ, Smith JE, Dworkin SI (1998) Training dose and session time as contextual determinants of heroin self-administration in rats. Pharmacol Biochem Behav 60:415-420
31. Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14(6):375-424
32. Mercadante S, Portenoy K (2001) Opioid-poorly responsive cancer pain. Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage 21:338-354
33. Moskowitz AS, Goodman RR (1985) Autoradiographic distribution of mu1 and mu2 opioid receptor binding in the mouse central nervous system. Brain Res 360:117-129
34. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257(5074):1248-1251
35. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 10:1298-1308
36. Oliverio A, Castellano C (1974) Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse. Psychopharmacologia 39:13-22
37. Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli-Rehfuss L, Baack E, Mountjoy KG, Cone RD (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72(6):827-834
38. Roselli-Rehfuss L, Mountkoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwisle ML, Simerly RB, Cone RD (1993) Identification of receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci 90(19):8856-8860
39. Rossi M, Bloom SR (2000) Central nervous system neuropeptides involved in obesity. In: Lockwood DH, Heffner TG (eds) Obesity: pathology and therapy. Springer-Verlag, Berlin Heidelberg New York, pp 313-341
40. Sandman CA, Kastin AJ (1981) Intraventricular administration of MSH induced hyperalgesia in rats. Peptides 2:231-233
41. Schiöth HB, Muceniece R, Mutulis F, Bouifrouri AA, Mutule I, Wikberg JES (1999) Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119. Neuropeptides 33:191-196
42. Starowicz K, Przewlocki R, Gispen WH, Przewlocka B (2002) Modulation of melanocortin-induced changes in spinal nociception by μ-opioid receptor agonist and antagonist in neuropathic rats. NeuroReport 13:2447-2452
43. Tatro JB (2000) Melanocortin receptor expression and function in the nervous system. In: Cone RD (ed) The melanocortin receptors. Humana Press, New Jersey, pp 173-207
44. Vergoni AV, Bertolini A, Mutulis F, Wikberg JES, Schiöth HB (1998) Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats. Eur J Pharmacol 362:95-101
45. Vergoni AV, Bertolini A, Wikberg JES, Schiöth HB (1999) Selective melanocortin MC4 receptor blockage reduces immobilization stress-induced anorexia in rats. Eur J Pharmacol 369:11-15
46. Von Roen JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ (1993) Physician attitudes and practice in cancer pain management. Ann Intern Med 199:121-126
47. Vrinten DH, Adan RAH, Groen GJ, Gispen WH (2001a) Chronic blockade of melanocortin receptors alleviates allodynia in rats with neuropathic pain. Pain Med 93:1572-1577
48. Vrinten DH, Kalkman CJ, Adan RAH, Gispen WH (2001b) Neuropathic pain: a possible role for the melanocortin system? Eur J Pharmacol 429:61-69
49. Vrinten DH, Gispen WH, Kalkman CJ, Adan RAH (2003) Interaction between the spinal melanocortin and opioid systems in a rat model of neuropathic pain. Anesthesiology 99:449-454
50. Wikberg JES, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, Skottner A (2000) New aspects on the melanocortins and their receptors. Pharmacol Res 42:393-420
51. Wilkinson WO (2000) The melanocortin-4 receptor. In: Cone Rd (ed) The melanocortin receptors. Humana Press, New Jersey, pp 475-490
52. Wilson BD, Ollmann MM, Barsh GS (1999) The role of agouti-related protein in regulating body weight. Mol Med Today 5:250-256
53. Winger G, Skoldager P, Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311-317
54. Zimmermann E, Krivoy W (1973) Antagonism between morphine and the polypeptides ACTH, ACTH 1-24 and beta-MSH in the nervous system. Prog Brain Res 39:383-392